Levetiracetam
Product Images NDC 58118-1112

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 58118-1112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Clinical Solutions Wholesale, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (5a86abbc 0e78 40d3 9ae6 F0cc78815cb5 01)

A dosing calculation formula illustrating how to determine total daily dose (mL/day) by multiplying daily dose in mg per kg per day by patient weight in kg, then dividing by the concentration of 100 mg/mL.*

FDA Label Image

Figure 2 (5a86abbc 0e78 40d3 9ae6 F0cc78815cb5 02)

A text panel showing formulas to calculate creatinine clearance (CLcr). The first formula adjusts for age, weight, serum creatinine, and sex (with a multiplier for females). The second formula adjusts CLcr for body surface area (BSA), normalizing to 1.73 m². This calculation relates to drug dosing considerations.*

FDA Label Image

Structure (5a86abbc 0e78 40d3 9ae6 F0cc78815cb5 03)

Chemical structure of the active ingredient levetiracetam, showing its molecular arrangement including a pyrrolidone ring attached to an ethyl group and an amide substitution.*

FDA Label Image

Figure 4 (5a86abbc 0e78 40d3 9ae6 F0cc78815cb5 04)

A bar chart depicting the percentage of patients by treatment group. The x-axis shows three groups: Placebo (N=95), Levetiracetam 1000 mg/day (N=97), and Levetiracetam 3000 mg/day (N=101). The y-axis indicates the percentage of patients, ranging from 0% to 45%. Bars reflect approximately 7.4% for placebo, 37.1% for Levetiracetam 1000 mg/day, and 39.6% for Levetiracetam 3000 mg/day, with asterisks marking the latter two groups.*

FDA Label Image

Figure 5 (5a86abbc 0e78 40d3 9ae6 F0cc78815cb5 05)

A bar chart comparing the percentage of patients for three groups: Placebo (6.3%, N=111), Levetiracetam 1000 mg/day (20.8%, N=106), and Levetiracetam 2000 mg/day (35.2%). The y-axis represents the percentage of patients, ranging from 0% to 45%, with statistical significance indicated by asterisks on the Levetiracetam bars.*

FDA Label Image

Figure 6 (5a86abbc 0e78 40d3 9ae6 F0cc78815cb5 06)

A bar chart comparing the percentage of patients between two groups: Placebo (N=104) and Levetiracetam 3000 mg/day (N=180). The y-axis represents the percentage of patients, with the Placebo group at 14.4% and the Levetiracetam group at 39.4%, marked with an asterisk above the Levetiracetam bar.*

FDA Label Image

Figure 7 (5a86abbc 0e78 40d3 9ae6 F0cc78815cb5 07)

A bar chart comparing the percentage of patients in two groups: Placebo (N=97) and Levetiracetam (N=101). The y-axis shows the percentage of patients, with the Placebo group at 19.6% and the Levetiracetam group at 44.6%. An asterisk marks the Levetiracetam bar.*

FDA Label Image

Figure 8 (5a86abbc 0e78 40d3 9ae6 F0cc78815cb5 08)

Bar chart comparing the percentage of patients in two groups: placebo (N=51) and Levetiracetam (N=58). The placebo group's bar reaches 19.6%, while the Levetiracetam group's bar is higher at 43.1%. The vertical axis is labeled '% of Patients' ranging from 0% to 45%.*

FDA Label Image

Figure 9 (5a86abbc 0e78 40d3 9ae6 F0cc78815cb5 09)

A bar chart comparing the percentage of patients responding to Placebo versus Levetiracetam. The y-axis represents the percentage of patients from 0% to 100%. The Placebo group (N=84) shows a 45.2% response rate, while the Levetiracetam group (N=79) shows a higher response of 72.2% with an asterisk indicating statistical significance.*

FDA Label Image

Levetiracetam 250mg Tablets

Levetiracetam 250mg Tablets label from Clinical Solutions Wholesale, LLC. The label includes the product NDC 58118-1112-8, quantity of 30 tablets, manufacturing and batch information, and repackaging details by Clinical Solutions Wholesale, LLC in Franklin, TN.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.